See also this year's filing and all EDGAR filings for this company.
PDF Report 0001080709_2016_Arena_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 3.0676881685149944, 'aggregate_val': 123975000, 'exp_sum': 30478000, 'exp_to_value': {'remainder_Revenues': 30478000}} |
Graph
Absolute values for 0001080709, Arena Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 174,838,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 7,775,000 |
| 2 | PropertyPlantAndEquipmentNet | 71,828,000 |
| 3 | remainder_Assets | 2,351,000 |
| 4 | LiabilitiesCurrent | 49,896,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,220,400 |
| 9 | ResearchAndDevelopmentExpense | 89,144,538 |
| 10 | remainder_Expenses | 14,260,981 |
| 11 | remainder_Revenues | 38,030,301 |
| 12 | remainder_NetIncome | 4,038,076 |
| 13 | remainder_ComprehensiveNetIncome | -5,298,039 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 256,792,000 |
| 1 | Liabilities | 49,896,000 |
| 2 | Expenses | 139,625,919 |
| 3 | Revenues | 38,030,301 |
| 4 | StockholdersEquity | 206,896,000 |
| 5 | NetIncome | -97,557,542 |
| 6 | ComprehensiveNetIncome | -100,206,562 |
| 7 | BaseVar | 246,840,168 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.29 |
| 9 | EconomicCapitalRatio | 3.22 |
Edgar->Model Mapping
Feature Distribution
Change over Time
